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Alzheimer’s Disease (AD) is an age-associated neurodegenerative disease that is the most 
common form of dementia in NZ. An emerging hypothesis is that the dysregulation of calcium 
(Ca2+) signaling driving synaptic transmission can lead to AD symptoms. Ca2+ plays an 
important role in the pre- and post-synaptic cell to initiate presynaptic neurotransmitter release 
and postsynaptic signal amplification. A protein critical in intracellular Ca2+ release on both 
sides of the synapse is the ryanodine receptor (RyR). Inappropriate release, or ‘leak’ of Ca2+ 
through RyR shows association with AD, however why this occurs is unknown. Ca2+ leak in 
cardiomyocytes has been attributed to the inappropriate ultrastructural placement and 
movement of RyR within the cell. Whether inappropriate trafficking of RyR occurs at the 
synapse in AD neurons is not known. Using Fluorescence Recovery After Photobleaching 
(FRAP) we have analysed the diffusion characteristics of RyR2 in HEK293 cells, giving a 
much-needed baseline for continued work in neurons. FRAP analysis showed RyR2 tagged 
with a green fluorescent protein had a significantly longer half-life compared to a freely soluble 
cytosolic protein (soluble GFP) (87.63 s ± 8.817 vs 7.99 s ± 3.88, respectively. p < 0.0001). 
RyR2-GFP half-life was also significantly longer than an Endoplasmic Reticulum (ER) 
entrapped soluble protein (CEPIA) (87.63 s ± 8.817 vs 9.63 s ± 1.13, respectively. p < 0.0001). 
Subsequent analysis of the diffusion coefficients of each protein showed that RyR2-GFP had 
a significantly lower diffusion coefficient than both CEPIA (0.017 µm2s-1 ± 0.001 vs 0.15 µm2s-
1 ± 0.02, respectively. p = 0.016) and soluble GFP (0.017 µm2s-1 ± 0.001 vs 0.6 µm2s-1 ± 0.2, 
respectively. p = 0.0035). Significance was tested using a Kruskal-Wallis non-parametric test 
with a Dunn’s post hoc test. Taken together these results suggest that membrane bound RyR2 
movement in the ER is significantly slower than two independent soluble proteins. Diffusion 
coefficients obtained in this experiment will be valuable for future work to determine if RyR2 
movement in neurons is a factor of simple diffusion or targeted transport. We have also 
 iii 
gathered preliminary data using the phenomena of Total Internal Reflection Fluorescence 
(TIRF) allowing a qualitative look at single RyR2-GFP protein movement. Future work will 
include tracking single labelled RyR2 in cultured neurons in an amyloid-beta treatment model 
of AD. This work will be the first to determine how RyR is trafficked within a cell and whether 
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1.1 Alzheimer’s Disease 
Alzheimer’s Disease (AD) is an age-associated neurodegenerative disease that is the most 
common form of dementia with approximately 6600 new patients identified annually in New 
Zealand (NZ) (Tobias et al., 2008). It becomes more important as population trends begin to 
shift; with the median age of the world’s population increasing annually (Lutz et al., 2008). 
Dementia is expected to increase in NZ from an estimated 1.3% of the total population in 2016 
to 2.9% of the total population in 2050, 50-70% of these patients being diagnosed with AD 
(Deloitte, 2017). Dementia has a great societal cost; surpassing that of cancer, heart disease 
and stroke combined (Wimo et al., 2013). This presents a growing need for the reallocation of 
scientific resources towards creating new therapeutic options. Between 2008 and 2016, the 
economic burden of AD to NZ increased by approximately $1.1 billion and is projected to 
increase to ~$4.5 billion by 2050 (Deloitte, 2017). A large percentage of this cost is associated 
with the prolonged time scale of the disease and the requirement for patients to be in intensive 
long-term care. Prevention of the onset of disease pathology by only 12 months is estimated to 
liberate more than $300 million every year (Deloitte, 2017). This shows that even a slight 
prevention in AD onset and progression can release a great socioeconomic burden on the 
country as well as relieve much suffering for the patient, whānau (family), and community. 
AD has a complex neuropathy but is generally characterized histologically by the accumulation 
of hydrophobic amyloid beta plaques, hyperphosphorylation of the tau protein and 
neurofibrillary tangles (Serrano-Pozo et al., 2011; Yao et al., 2020). It is often linked with 
neuroinflammation, impaired cerebral blood flow, widespread neurodegeneration and more 
recently degradation via lysosomes and recycling via autophagy (Van Acker et al., 2019). Prior 
to AD diagnosis, some patients can present with a less severe condition termed mild cognitive 
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impairment (MCI), suggesting a potential risk factor or precursor to the development of the 
disease (Bruno et al., 2012). MCI can be characterized by impaired memory formation of recent 
events, progressive cognitive decline, and global dementia (Van Acker et al., 2019). It is 
thought to represent a transitional state between normal brain function and AD, however not 
all patients presenting with symptoms of MCI will progress to AD (Boyle et al., 2006). The 
majority of AD cases manifest as a late onset sporadic form of the disease, however some 
literature also identifies a significant proportion of AD cases can be caused by genetic factors 
(Familial Alzheimer’s Disease (FAD) (Tanzi et al., 1996)). In contrast to the more common 
sporadic version of AD whose etiology still remains elusive, FAD is well characterized and 
involves inherited autosomal dominant mutations in either the amyloid precursor protein 
(APP), or presenilins (PS1 or PS2) (George-Hyslop et al., 1989; Tanzi & Bertram, 2005). 
However, more recent research suggests that other factors could potentially play a role in the 
onset and progression of AD (Chakroborty & Stutzmann, 2011). 
 
1.1.1 Amyloid Beta vs Calcium Dysregulation Hypothesis of AD 
The most common hypothesis for the primary pathophysiological events occurring in AD is 
the amyloid beta cascade hypothesis, which has dominated the field for over 20 years (Hardy 
& Higgins, 1992; Selkoe & Triller, 2008; McGeer & McGeer, 2013). However, despite the 
intense research efforts focusing on this hypothesis, no significant treatment options have been 
developed. The amyloid beta hypothesis states that the overaccumulation of the Aβ peptide, 
either by increased cleavage of APP or by reduced clearance is essential for the development 
of the disease (Hardy & Higgins, 1992; McGeer & McGeer, 2013). It is well established in the 
literature that indeed Aβ does accumulate to neurotoxic levels in AD and mutations causing an 
FAD phenotype show enhanced production of amyloid beta plaques in animal models (George-
Hyslop et al., 1989; Tanzi & Bertram, 2005). However, clinical trials focusing on the Aβ 
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hypothesis have failed to produce a single new therapy in the last 20 years (McGeer & McGeer, 
2013). Previous evidence also suggests that both insoluble Aβ plaques and tau neurofibrillary 
tangles are present in the hippocampus and neocortex in non-demented older individuals 
without AD symptoms and are hypothesized by Arriagada et al. to be at similar levels 
(Arriagada et al., 1992; Schmitt et al., 2000).  
 
More recent research begins to implicate the breakdown of synaptic communication as one of 
the causative agents in the cognitive deficits seen in AD rather than Aβ directly (Lipton et al., 
2001; Citri & Malenka, 2008; Südhof et al., 2009; Adasme et al., 2011). Perhaps, more 
importantly a new emerging hypothesis has been presented that indicates the dysregulation of 
calcium (Ca2+) signaling in synaptic transmission can directly result in an AD phenotype (Jorge 
et al., 2003; Giacomello et al., 2005; Chakroborty & Stutzmann, 2011). This new hypothesis 
postulates that dysregulation of Ca2+ signaling at the synapse could be a cause for the early 
pathology seen in AD (Berridge, 2010; Wang et al., 2017; More et al., 2018). However, it is 
very controversial in the literature which comes first; although AD causes alterations in Ca2+ 
homeostasis it is unknown whether this is caused by the increase in Aβ plaques. Or, in contrast, 
whether the dysregulation of Ca2+ signaling causes an increase in the Aβ plaques similar to 
FAD mutations (Tanzi et al., 1996). This highlights the emergence of several contrasting 
themes in the literature when understanding the onset and progression of AD. 
 
1.2 Synaptic Transmission  
Synaptic transmission is an essential physiological process that occurs between neurons 
throughout the body and is regulated by common intracellular signaling molecules such as 
Ca2+. Ca2+ plays an important role in both the presynaptic axon terminal and the postsynaptic 
bouton to initiate processes such as Calcium Induced Calcium Release (CICR), 
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neurotransmitter release, and amplification of neuronal signals (Collin et al., 2005; Adasme et 
al., 2011). In a presynaptic bouton, depolarization causes Ca2+ influx via ion channels such as, 
Voltage Gated Calcium Channels (VGCC); inducing release of Ca2+ from the endoplasmic 
reticulum (ER)(Collin et al., 2005). Release of the large intracellular Ca2+ stores from the ER 
leads to vesicular fusion and the release of neurotransmitter into the synaptic cleft, which acts 
on membrane bound postsynaptic receptors to cause depolarization, altered gene transcription 
and synaptic plasticity (Collin et al., 2005; Adasme et al., 2011; Del Prete et al., 2014). CICR 
also occurs in postsynaptic boutons where Ca2+ plays an important role in signal amplification, 
synaptic plasticity for memory storage and the beginning of a variety of metabolic processes 
(Del Prete et al., 2014). Consequently, disturbances in either pre- or post- synaptic Ca2+ 
signaling can have devastating effects on synaptic transmission and hence neuronal function 
(Figure 1).  
 
Figure 1: (A) Normal synaptic transmission. Depolarization leading to calcium induced calcium release, endoplasmic 
reticulum Ca2+ release, vesicular fusion, neurotransmitter release, post-synaptic depolarization, and propagation of neuronal 
signal. (B) Ca2+ leak from Ryanodine Receptor 2 on the endoplasmic reticulum leading to vesicle depletion and reduced 
neurotransmitter release. Dampened postsynaptic signaling. Original image created with BioRender.com. 
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1.2.1 RyR-Mediated Calcium Release 
The main Ca2+ release channels located on the ER membrane are the ryanodine receptor (RyR) 
and the inositol triphosphate receptor (IP3R) (Chakroborty & Stutzmann, 2011). While the IP3R 
is activated by the second messenger known as IP3, RyR is sensitive to cytosolic Ca2+ and is 
heavily involved in CICR (Adasme et al., 2011; Chakroborty & Stutzmann, 2011). RyR 
isoform two (RyR2) has mainly been studied in the heart as it is a key player in cardiomyocyte 
contraction (George & Lai, 2007). However, a growing body of evidence has shown its 
presence in the hippocampus and have implicated it as a major player in synaptic transmission 
(Adasme et al., 2011; Zhang et al., 2015). Accordingly, several studies associate increasingly 
uncontrolled leak of Ca2+ from the ER through RyR2 with the progression of AD symptoms 
(Del Prete et al., 2014; Briggs et al., 2017; Lacampagne et al., 2017). Many AD mouse models 
(APP/PS1, PS1KI and 3xTg-AD) have shown a pathological increase in Ca2+ leak along with 
increased RyR2 expression (Smith et al., 2005; Del Prete et al., 2014). Bruno et al. have noted 
an increase of RyR2 expression in MCI, similar to the increase seen by Liu et al. in an APP/PS1 
mouse model of AD (Bruno et al., 2012; Liu et al., 2014a). The APP/PS1 transgenic mouse 
model used by Liu et al. contained both a mutation in the APP gene (KM670/671NL) as well 
as a mutated PS1 protein (L166P), which lead to increased RyR2 expression, cerebral 
amyloidosis, and neuroinflammation (Liu et al., 2014a) (Radde et al., 2006). This hypothesis 
has been heavily debated however, as a study using a presenilin conditional knockout mouse 
(PS1KI), triggered a reduction of hippocampal RyR2 levels (Bei et al., 2013). The reason behind 
these contradictory results of RyR2 expression in AD pathology may be linked to a variable 
regulation of RyR2 along AD pathology development and between brain regions (Del Prete et 
al., 2014). One researcher has already drawn attention to the complex regulation of RyR2 
expression in human AD brains, where RyR2 expression was shown to be elevated in 
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hippocampal regions in patients with early neurofibrillary pathology and reduced in the 
subiculum in patients determined to be in a later stage of the disease (Kelliher et al., 1999).  
 
The Ca2+ leak seen in AD is proposed to be a direct result of hyperactive RyR2 during CICR 
creating a larger amount of ‘leak’ even in the absence of stimuli (Lacampagne et al., 2017). 
RyR2 mediated Ca2+ leak (Ca2+ sparks) events generally occur when ER Ca2+ levels surpass a 
certain threshold which has been coined store overload induced calcium release (SOICR) 
(Jones et al., 2008). Recent work in the heart has implicated an intrinsic sensor within RyR2 
that allows for ER Ca2+ to activate the receptor leading to SOICR; this potentiates RyR2 as a 
pivotal protein in the pathological leak of Ca2+ (Chen et al., 2014). Factors such as caffeine, 
hereditary arrhythmogenic disease-causing mutations and post-translational modifications 
such as oxidation and phosphorylation can all increase the sensitivity of RyR2 to ER Ca2+, 
which reduces the threshold for SOICR (Xiao et al., 2007; Jones et al., 2008; Kong et al., 2008; 
Waddell et al., 2016). Importantly, research has shown the same mechanism can also occur in 
the brain, where these same hereditary mutations can cause seizures irrespective of the effects 
on the heart (Lehnart et al., 2008). Increased Ca2+ leak from RyR2 can cause depletion of 
vesicle pools, decreased neurotransmitter release, and is thought to drive postsynaptic 
afterhyperpolarization (Figure 1B) (Chakroborty et al., 2012). Together these are hypothesized 
to result in cognitive disfunction and memory deficits (Disterhoft & Oh, 2007; Zhang et al., 
2015). Several authors have considered these effects and have shown that mice models 
expressing ‘leaky’ RyR2 channels have a range of neuronal impairments including AD-like 
symptoms (Lacampagne et al., 2017). Inversely, reducing RyR2 activity and Ca2+ leak using 
specific antagonists, shows improved cognitive function and a delay in the onset of symptoms 




1.3 Ryanodine Receptors  
In the heart, RyR2 is implicated in Ca2+ leak as well as SOICR, which has been shown to lead 
to altered cellular function, arrhythmias, and other cardiomyopathies (George & Lai, 2007). 
One reason why RyR2 becomes ‘leaky’ in the heart is suggested to be changes in RyR2 
expression levels and ultrastructural location (Figure 3 and 4) (Galice et al., 2018; Jones et al., 
2018). The last decade has seen major advancements regarding the two main structural features 
of RyR2 in cardiomyocytes. Firstly, Kolstad et al. described the correct trafficking and 
placement of RyR2 within a structure known as the cardiac dyad (Figure 2) is essential for a 
lower propensity of Ca2+ leak (Kolstad et al., 2018).  
 
 
Figure 2: (C) Isolated T-tubule in a cardiomyocyte showing the structure of the cardiac dyad. Calcium induced calcium 
release causes Ca2+ release from the sarcoplasmic reticulum which binds the myofilaments, causing contraction. Original 
image created with Biorender.com. 
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Secondly, they describe that at the cardiac dyad individual RyR2 channels can form discreet 
clusters and the arrangement and size of these clusters can directly affect the activity of the 
receptor (Kolstad et al., 2018). Tightly clustered RyR2 is thought to be more stabilized and 
reduces the amount of Ca2+ leak from the sarcoplasmic reticulum (SR) (Figure 3 and 4) (Galice 
et al., 2018). Fortunately, due to its close association with arrhythmia and heart failure, there 
has been a large effort to determine compounds that can regulate the activity of RyR2 (Lehnart 
et al., 2006).  
 
 
Figure 3: (D) Hypothesized reduction in Ca2+ leakage from the endoplasmic reticulum caused by tightly packed receptor 
clusters. (E) Hypothesized increase in propensity of Ca2+ leak caused by the reduced interaction between individual ryanodine 
receptors or an increase in number of RyR2. Original image created with BioRender.com. 
Perhaps most importantly, researchers in the United States have recently reported the same 
structure-function relationship in hippocampal neurons, where a larger cluster size correlates 
with an increased Ca2+ spark frequency (Vierra et al., 2019). Researchers have postulated that, 
an alteration of RyR2 cluster location and size could be an important causal step to the 
development of uncontrolled Ca2+ homeostasis driving pathological changes in synaptic 
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transmission (Serrano-Pozo et al., 2011; Del Prete et al., 2014). Preliminary data at the 
University of Otago depicts that RyR2 clusters are larger in an APP/PS1 (delExon9) mouse 
model of AD, however it is unclear whether this is caused by an increase in the number of 
receptors in the cluster or an alteration in the spatial interaction between individual RyR2 
(Vergara, 2020).  
 
Figure 4: Super-resolution (direct stochastic optical reconstruction microscopy) images of Ryanodine receptor 2 
clusters in cardiomyocytes in (F) control (healthy) hearts and (G) heart failure hearts. Correct trafficking of RyR2 to 
cardiac dyad is evident in control cardiomyocytes shown as tight clusters and vertical striations, compared to disorganized and 
dispersed in heart failure. Image adapted from Kolstad et al., 2018. 
1.4 RyR2 movement characteristics 
The inability to correctly traffic and place other neuronal proteins (Lee et al., 2002) has been 
implicated in the initiation and progression of AD in conjunction with altered Ca2+ leak 
(Chakroborty & Stutzmann, 2011; Vicario-Orri et al., 2015). However, the trafficking or 
movement of RyR2 has not been fully characterized in any cell, particularly in neurons. Hiess 
et al. have shown that RyR2 clusters can redistribute within cardiomyocytes with movements 
of ~1 μm in minutes, however the speed of intra-cluster rearrangement remains largely 
unknown (Hiess et al., 2018). This suggests that movement of RyR2 clusters and individual 
channels is dynamic and an important part in the normal regulation of receptor function. Even 
though RyR2 has a pivotal role in synaptic transmission, there remains limited information on 
its movement and ultrastructural location at the synapse; consequently, leaving a large gap in 
the literature that is yet to be filled. Although it is unclear whether RyR2 movement in neurons 
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is dominated by directed trafficking or by random thermal motion/diffusion (Brownian 
motion), Liu et al. have depicted that RyR2 can form a complex with KIF3A a member of the 
kinesin-2 motor protein family (Liu et al., 2014b). This is the first quantifiable evidence to 
suggest that RyR2 movement is not only isolated to random diffusion along the ER.  
 
1.4.1 Targeted transport 
Axonal transport can occur in both an anterograde and retrograde fashion along cytoskeletal 
polymer tracks known as microtubules or microfilaments (Vicario-Orri et al., 2015). 
Microtubules; the main component of the cytoskeleton are made up of an α- and β-tubulin 
heterodimer that undergoes continuous polymerization and depolymerization to create a 
polarized, dynamic tubular structure (Stokin & Goldstein, 2006; Vicario-Orri et al., 2015). 
There are two main superfamilies of motor proteins (kinesins and dyneins) that each have a 
different role in protein trafficking (Vicario-Orri et al., 2015). Kinesin motor proteins associate 
with microtubules and travel in an anterograde fashion towards the positive end of the 
polymeric structure (Kapitein & Hoogenraad, 2011). In contrast, while dyneins also associate 
with microtubules they travel in retrograde towards the negative end of microtubules (Kapitein 
& Hoogenraad, 2011). Axonal transport can be divided into fast and slow transport, 
differentiated by the movement rates and cargos involved (Vicario-Orri et al., 2015). Cellular 
constituents undergoing slow anterograde transport are mainly cytoskeletal components and 
travel at speeds of ~20-50 nm/s (Shah & Cleveland, 2002; Baas & Buster, 2004), whereas fast 
axonal transport (FAT) mainly involves the movement of synaptic vesicles and organelles 




1.4.2 Axonal trafficking and Tau  
Tau is a microtubule-associated protein (MAP) involved in microtubule dynamics and 
maintenance (Amos & Schlieper, 2005). However, it has been shown that this protein can 
become hyperphosphorylated in AD leading to the neurofibrillary tangles that are a hallmark 
of the disease (Mandelkow & Mandelkow, 1998). Axonal transport is highly reliant on 
microtubule tracks regulated by tau and as such, the effects of tau aggregates on FAT has been 
explored by multiple research groups (Ebneth et al., 1998; Seitz et al., 2002; Stamer et al., 
2002). Several studies have shown an overexpression of tau inhibits axonal transport, however 
the molecular mechanism behind this is yet to be elucidated (LaPointe et al., 2009). A proposed 
mechanism for tau inhibition of kinesin-based transport suggests a competition between tau 
and kinesin-1 for the kinesin-1 binding site on microtubules (Ebneth et al., 1998; Stamer et al., 
2002). However, this is still controversial as Yuan et al. reported that the overexpression of 
wild type tau did not alter rates of axonal transport in vivo (Yuan et al., 2008). As there is an 
ongoing dispute in the scientific community surrounding the exact effect AD has on axonal 
transport it remains a large area for continued research. 
 
1.4.3 Intracellular diffusion (Brownian motion) 
Membrane proteins such as RyR2 and other macromolecules are thermally driven to diffuse 
within cells allowing the formation of protein oligomers or lipid-protein complexes (Vaz et al., 
1984). Fick’s first law of diffusion shows that the relationship between the diffusive flux and 
concentration gradient relies on both the temperature and viscosity of the medium in which it 
moves (Fick, 1855). Although RyR2 protein localization is important in cardiomyocytes, no 
previous research has developed a method for determining its lateral diffusion characteristics 
in the ER membrane. Protein diffusion in protein-poor environments is well understood (Peters 
& Cherry, 1982). Experimental data has provided compelling evidence that for a membrane 
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protein with a lateral radius of R the diffusion coefficient D scales logarithmically as D ∝ 
ln(1/R) (Ramadurai et al., 2009). This logarithmic dependence of D on R is described by the 
Saffman-Delbrück (SD) model derived from protein-poor conditions linking the diffusion 
coefficient with the physical properties of the lipid membrane and the surrounding solvent 
(Saffman & Delbrück, 1975). This model suggests the diffusion coefficient relies weakly on 
the radius of the protein. However, this model neglects the crowding-induced anomalous 
diffusion seen in a protein-rich environments (Guigas & Weiss, 2016; Metzler et al., 2016). 
Protein-rich environments such as the ER, show a higher dependence on the lateral radius of a 
protein and demonstrate the development of a stronger Stokes-Einstein relationship where D 
∝	1/R	(Javanainen et al., 2017).  
 
1.5 Summary 
AD has been characterized for many years by the overaccumulation of the Aβ peptide. Recent 
work begins to move away from this hypothesis and starts to implicate the breakdown of Ca2+ 
in synaptic transmission as a causative agent in the development of the disease. Although the 
ultrastructural organization and movement of the RyR2 is essential in several tissues, research 
remains limited about its movement characteristics in neurons. To the best of our knowledge 
and referring to preliminary data from the University of Otago, RyR2 cluster size is increased 
at the synapse in an APP/PS1 (delExon9) model of AD (Vergara, 2020). However, it is yet to 
be examined if this is caused by alterations in the balance between retrograde and anterograde 
trafficking, an alteration in the normal diffusion characteristics of RyR2 or an entirely different 
mechanism. Similar to the heart, alterations in RyR2 movement could prove essential to the 





The aim of this research was to investigate the random thermal motion of ER bound RyR2-
GFP to develop a robust methodology for the quantification and monitoring of RyR2 using a 
non-polarized recombinant cell line. There were two main objectives: 
• Analyze the diffusion characteristics of RyR2 using fluorescence recovery after 
photobleaching (FRAP). To date there has been no published research dedicated to 
understanding the basic Brownian motion of RyR2 clusters. This study aimed to take 
the first steps by prioritizing basic quantifiable data for RyR2 at room temperature 
such as half-life of recovery and diffusion coefficient. 
• Analyze and track single RyR2 clusters using total internal reflection 
fluorescence (TIRF). This study aimed to estimate the movement speed resulting 
from random thermal movement and develop a methodology for future work in 
cultured hippocampal neurons. 
 
1.5.2 Hypothesis 
Based on these aims it was hypothesized that: 
• The large ER bound RyR2-GFP would move slower than both a soluble organelle 
entrapped protein (CEPIA) and a small soluble cytosolic protein (GFP). Slower 
movement would create a longer half-life as it takes longer to recover and a smaller 
diffusion coefficient as its movement is restricted within the ER membrane. 
• RyR2 moves at speeds similar to that seen in cardiomyocytes at approximately 1 µm 
in minutes.  






2.1 HEK293 Cell Culture 
Cryopreserved stable inducible RyR2-GFP HEK293 cells, were generated with a Flp-In T-REx 
Core Kit (Life Technologies) by Professor Wayne Chen (University of Calgary, Canada). 
These cells were stored in 1 ml aliquots at -80°C in Dulbecco’s modified eagle medium 
((DMEM), Life Technologies), that was supplemented with 10% fetal bovine serum ((FBS), 
Life Technologies), 1% L-Glutamine (Sigma), 1% non-essential amino acids ((NEAA), Life 
Technologies), and 1% penicillin and streptomycin suspended with 10% anhydrous dimethyl 
sulfoxide ((DMSO), Thermo Fisher) until needed. HEK293 cells were thawed with pre-
warmed fresh DMEM at 37°C and cultured in 75cm2 cell culture flasks suspended in 30ml 
DMEM. After 24 hours (~90% confluence) in a humidified incubator maintained at 37°C with 
5% CO2, the DMEM was replaced to remove DMSO to allow subculturing.  
 
2.1.1  Sub-culture 
After reaching ~90% confluence HEK293 cells were sub-cultured into a separate cell culture 
flasks (25cm2 or 75cm2) in a laminar flow tissue culture hood. Existing DMEM was removed 
via vacuum suction without agitating the cells inside the culture flask. To remove any 
remaining DMEM and debris, the cells were washed twice with 2ml of sterile phosphate 
buffered saline ((PBS: 137 mM NaCl (Lab supply), 2.7 mM KCl (Sigma), 100 mM 
NaHPO4.7H2O (VWR Global Science), 2 mM KH2PO4 (Thermo Scientific), pH of 7.4). 
Following washing, cells were suspended in 1ml of PBS and placed back into the incubator for 
5 minutes, allowing the cells to detach from the floor of the culture flask. Given enough time 
to detach, cells were agitated for complete detachment from the interior wall. 6.5ml or 17ml of 
DMEM was added back into the culture flask to make a total of 7.5ml or 20ml of solution. 
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Pipetting slowly repeatedly ensures adequate mixing of the PBS and DMEM. This cell mixture 
was then added to separate culture flasks following Table 1 or to 6-well plates for live cell 
imaging. An inverted microscope (Olympus CKX41) was used to assess cell confluence and 
confirm absence of bacterial or fungal contamination.  
Table 1: Components of cell culture solution dependent on the number of days confluence is achieved. 
 Ratio Cell Culture Solution 
1 Day 1:1 3.75 ml DMEM 
3.75 ml cell mix 
2 Days 1:2 5 ml DMEM 
2.5 ml cell mix 
3 Days 1:4 6 ml DMEM 
1.5 ml cell mix 
 
2.1.2 Plating  
For the purposes of live cell imaging HEK293 cells were grown on multiple glass coverslips 
(25mm wide, #1.5 thickness coverslip ~170 µm) in a 6-well plate. These coverslips were 
sterilized with 70% ethanol before they were placed in each well (1 coverslip per well). 
Following this, the coverslips were coated with poly-L-lysine (Sigma) and left for ~10 minutes 
to ensure adequate adhesion. Poly-L-lysine was removed with vacuum suction and 2 ml 
DMEM was added to each well containing a coverslip. 1 ml of cell mix created in the 
subculture process (section 2.1.1) was diluted in 6ml of DMEM (1:6 ratio) and slowly pipetted 
up and down to create a homogeneous solution. 1ml of this diluted mixture was added to each 
well to create a total volume of 3ml per well and placed back into the incubator for 72 hours 
or until 90% confluence was reached. 
 
2.1.3 cDNA Transfection 
Ca2+ phosphate precipitation-mediated transfection of CEPIA and soluble GFP was carried out 
on plated HEK293 cells 40 - 48 hours before imaging to trigger transient expression of the 
protein of interest. Ca2+- measuring organelle-entrapped protein indicator (CEPIA) was used 
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for visualization of the endoplasmic reticulum in both FRAP (section 2.2.1) and TIRF (Section 
2.2.2), while soluble GFP was used for soluble protein dynamics only in FRAP. The 
components of the transfection mix are outlined in the table below (Table 2). Each well was 
transfected with 0.18 µg of cDNA, 40 – 48 hours before imaging. Under the laminar tissue 
culture hood, the cDNA solution was added drop-by-drop to 250 µl of 2 x HEPES buffer to 
create a total volume of 500 µl. 180 µl of this solution was added to each well in a side to 
side/back and forth motion to ensure even distribution, then placed back into the incubator 
pending RyR2-GFP induction. 
Table 2: Components of cDNA transfection mix and depictions of the plasmid vectors used for transfection of both 
soluble GFP and CEPIA. 
Component Volume Supplier 
Tube 1 
2 M CaCl2 31 µl Thermo Fisher 
MilliQ  211 µl  
Soluble GFP or 
CEPIA cDNA 
(0.18µg per well) 
7.04 µl Prepared in lab 
Tube 2 
2 x HEPES (pH 7.05) 250 µl  






2.1.4 HEK293 Cell induction  
The Flp-In T-Rex system used by Professor Wayne Chen to create the RyR2-GFP HEK293 
cells in this study is a tetracycline inducible expression system. Therefore, RyR2-GFP 
expression was induced using (1 µg/ml) tetracycline 15-20 hours before imaging. After 
removing existing DMEM growth media, each well in a 6-well plate containing a coverslip 
was washed with 3ml new DMEM twice. Using a 1:1 ratio, 1 µl of 1 mg/ml concentration of 
tetracycline was added per 1 ml of DMEM in a separate 50 ml falcon tube. 3 ml of the 
DMEM/tetracycline mix was added to each well and the plate was then placed back into the 
incubator for ~18 hours to reach ~80-90% confluence before FRAP or TIRF analysis. 
 
2.2 Live Cell Imaging 
2.2.1 Fluorescence Recovery After Photobleaching (FRAP) 
FRAP analysis is a technique used for the measurement of the diffusion of fluorescently labeled 
proteins or macromolecules (Periasamy & American Physiological Society, 2001). Using a 
high intensity 488 nm laser, a brief pulse irreversibly bleached fluorescence molecules in a 
circular region of interest (5 µm in diameter; 19.6 µm2 area). With an attenuated probe beam, 
the diffusion of unbleached fluorescent molecules into the bleached area of interest was 
measured as a quantitative index of diffusion characteristics (Figure 5). The net result of 
photobleached molecules moving out of the region of interest and unbleached fluorescent 
molecules moving into the bleached volume was a recovery in fluorescence that was 
proportional to the mobility of the molecules. Using an appropriate mathematical model, we 
extracted quantitative information on the molecular dynamics of molecules of interest (Lorén 





Figure 5: Example image sequence of FRAP on RyR2-GFP transfected HEK293 cells. Area (1) corresponds to the region 
of interest that was photobleached and monitored for fluorescence recovery. Area (2) corresponds to the non-bleached cell 
area that was used to correct for acquisition bleaching. Area (3) corresponds to the background area of image acquisition and 
was used to normalise fluorescence intensity’s and remove background noise. 
A Nikon A1R Multi-Photon Confocal Laser Scanning Microscope (Kurobane Nikon Co.) was 
used with a 25x Apo LWD (1.0 NA) multi-immersion objective with a 488nm excitation laser 
to visualize fluorescently labeled proteins. Coverslips were checked for contamination and 
appropriate confluence under an inverted light microscope (Olympus CKX41) then placed 
individually into a 60 x 15 mm petri dish and secured in place. Subsequently, 2ml of 1mM 
KRH (125 mM NaCl, 25 mM HEPES, 12.5 mM D-Glucose, 5mM KCl, 1.2mM MgCl2) was 
added to the petri dish to maintain cell viability. Laser scanning confocal microscopy greatly 
increased the resolution, contrast, and quality of our images, creating two-dimensional profiles 
containing both spatial and temporal information. However, imaging limitations (diffraction 
limit of light) reduced small particle discrimination preventing individual RyR2-GFP 




2.2.1.1 Image Acquisition  
Cells were focused on and isolated based on visual appearance of protein expression. An initial 
baseline measurement was taken before photobleaching for each cell and totaled 15.2 seconds 
(9 frames) at 0.59 frames per second (FPS). A 19.6 µm2 area within the cell was subsequently 
photobleached with a high intensity 488nm excitation laser for 6.8 seconds (4 frames) at 0.59 
FPS. Recording then occurred continuously for with 5 minutes (RyR2-GFP – 296 frames) or 3 
minutes (CEPIA and soluble GFP – 177 frames) at 0.99 FPS.  
 
2.2.1.2 Data Analysis 
Using Nikon Elements C equipped on a Windows 7 computer, recordings were saved and 
exported into Fiji (ImageJ). The mean fluorescence intensity value within the region of interest 
was corrected at each frame by subtracting the mean intensity of a background region distal 
from it (Figure 5). 
𝐼	(𝑡) = 𝐼!"#$%&#'	)#*+,-(𝑡) − 𝐼!$%.*),/-'(𝑡) 
Where I (t) is the measured fluorescence intensity at a given time, t. The normalization of 
recovery Rnorm(t) was calculated according to the formula: 
𝑅-,)0(𝑡) = 100	 ×	
𝐼	(𝑡)
𝐼(0) 
Where I (0) corresponds to the region’s mean intensity directly before bleaching and remains 
constant for individual cells. To account for bleaching caused by the imaging process 
(acquisition bleaching), additional correction was preformed using mean intensity values of a 
distal non-bleached region within the cell: 







Where Rnorm(non-bleached region) corresponds to the mean intensity value of the non-bleached 
region at each time point (Figure 5). To obtain FRAP percentages from these values the 
following formula was used: 





Where Rcorrected(1) corresponds to first time point after bleaching and Rcorrected(0) is the last time 
point before bleaching (i.e Rcorrected(0) = 100%). Recovery curves for all cells were plotted 
using GraphPad Prism V.9 following a characteristic exponential FRAP equation: 
𝑦 = 	𝑦2	 + (𝑃𝑙𝑎𝑡𝑒𝑎𝑢 − 𝑦2)(1 − 𝑒(4.5)) 
Where y is FRAP % and x is time. The exponential recovery begins immediately after bleaching 
where y0 is equal to 0, therefore: 
𝑦 = 𝑃𝑙𝑎𝑡𝑒𝑎𝑢	 × (1 − 𝑒(4.5)) 
 
Figure 6: Characteristic FRAP recovery curve. Original image 
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Cells were excluded if they had an R2 value that did not follow a characteristic FRAP recovery 
curve. Half-life (tau ½) is defined as the time it takes for the cell to recover to half of its plateau 
level, therefore, it can be calculated by rearranging the exponential equation above to find the 
x value when y is ½ Plateau: 
1




𝑃𝑙𝑎𝑡𝑒𝑎𝑢 = 1 − 𝑒
(4.5) 
1









Diffusion coefficients were calculated for a circular region of interest (bleached region) with a 







Both half-life and diffusion coefficients were compared with a non-parametric Kruskal-Wallis 
test to identify significant differences. 
 
2.2.2 Total Internal Reflection Fluorescence Microscopy 
The phenomena of Total Internal Reflection Fluorescence (TIRF) exploits the properties of 
light to optically section sample regions within the close vicinity of the substrate where the 
field is induced (Martin‐Fernandez et al., 2013). In biological cell work, the interface where 
the evanescent field is created is usually between the glass coverslip and a film of aqueous 
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solution (DMEM, ~N = 1.345) between the coverslip and the cells adhered to it (Martin‐
Fernandez et al., 2013). TIRF isolates a two-dimensional section within three-dimensional 
HEK293 cells and monitors a plane located closely to the glass (~N = 1.51) of a 25mm 
coverslip. The exploitation of a small penetration distance can result in images as close as 200 
nm from the boundary of the coverslip (Midorikawa, 2018). 
 
TIRF was carried out on an Andor Dragonfly Spinning Disk Confocal Laser Scanning 
Microscope mounted on an inverted Nikon microscope (Nikon Eclipse Ti-E2, Nikon) with 
Perfect Focus System (Nikon), equipped with an iXon 888 EMCCD camera (Andor), and two 
Zyla 4.2 sCMOS cameras (Andor) and controlled by Fusion software (Andor). To keep 
samples at 37°C (HEK293 cells), a stage top incubator (OKOLabs) was used. An ET-GFP filter 
set (Chroma) was used for imaging proteins tagged with GFP. 
 
2.2.2.1 Image Acquisition 
Cells were focused on with a Nikon CFI Apo TIRF 60x NA 1.49 oil objective (Nikon) using a 
TIRF critical angle and imaged for a total of 3 minutes and 30 seconds (total of 204 frames ~ 
1.03 FPS). For imaging, a 488-nm laser was used for excitation. An AttofluorTM cell chamber 
(ThermoFisher) was used to secure 25mm coverslips submerged with 1 ml of DMEM for the 
imaging process.  
 
2.2.2.2 Data Analysis 
Cell were analyzed qualitatively where the distance traveled by an RyR2-GFP cluster was 
monitored over multiple imaging frames. Cluster is used as a description of a discrete 
fluorescent puncta. From the current images it is not possible to determine if this is a true single 
RyR2-GFP cluster or multiple clusters moving in unison. Measurements of the distance 
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traveled over a specific length of time was used to approximate the average speed of an RyR2-
GFP cluster in microns per second. Fluorescent RyR2-GFP particles were tracked over ~3 
minutes and distance traveled was measured in µm (Figure 12). 
 
2.3 Statistical Analysis 
One-way analysis of variance (ANOVA) can be used to test for significant differences between 
the means of three or more independent groups. However, it assumes that data is both normally 
distributed and shows equal variance between groups. To determine if use of a one-way 
ANOVA was an appropriate way to show significance between groups in FRAP data, we first 
tested for a normal distribution of raw data points for CEPIA, soluble GFP and RyR2-GFP’s 
using the Shapiro-Wilk test, which showed all data were normally distributed and had the 
potential to undergo a one-way ANOVA. Next, we tested raw K values, half-life, and diffusion 
coefficient for each protein for equal variance between groups using a Brown-Forsythe test, 
which showed unequal variance in K values, half-life, and diffusion coefficient, hence 
eliminating a one-way ANOVA as the statistical analysis used to compare our data. Therefore, 
the non-parametric Kruskal-Wallis test was used with a Dunn’s post hoc test to determine any 
significance between groups for all three data sets (K value, half-life, and diffusion coefficient) 
for our FRAP data. A *p <0.05 was considered significant. Relevant p values are presented in 
each figure legend. Multiple comparisons were made between RyR2-GFP vs CEPIA as well 






The overall aim of this research was to investigate the movement characteristics of RyR2-GFP 
clusters in HEK293 cells as a method of determining background diffusion rates within cells, 
prior to investigating motion in neurons. HEK293 cells have been used extensively to study 
RyR2 function and display Ca2+ leak events analogous to cardiac and neuronal cells, suggesting 
RyR2 likely forms clusters with similar characteristics (Jiang et al., 2004; Kong et al., 2008). 
They are easy to modify with different fluorescent proteins to quickly optimize experimental 
and imaging protocols. It was hypothesized that the membrane bound RyR2-GFP would move 
slower compared to two independently soluble proteins. HEK293 cells contained either RyR2 
tagged with a Green Fluorescent Protein (RyR2-GFP), CEPIA (as a marker of ER protein 
movement) or GFP (as a marker of cytosolic protein movement). Results are split into bulk 
movement and single protein movement, with each being crucial to elucidate the dynamic 
mobility of RyR2-GFP in HEK293 cells.  
 
Firstly, bulk movement characteristics were studied using the well-known FRAP technique 
(Section 2.2.1), where recovery curves were analyzed for the three different proteins. Secondly, 
to discriminate individual particles and at a higher resolution, TIRF analysis (Section 2.2.2) 
was used. TIRF exploits the properties of light to image in the close vicinity of the coverslip 
used for cell culture. Measurements of distance traveled over a specific length of time can be 
used to approximate the average speed of an RyR2-GFP cluster in microns per second. Due to 





3.1 Bulk movement 
FRAP data allows characterization of bulk motion of RyR2-GFP in the ER by comparing its 
fluorescence recovery with both a soluble ER protein and a soluble cytosolic protein. The mean 
± SEM for all proteins follow a non-linear regression curve that can be plotted using an 
exponential equation (Figure 7B). The mean FRAP percentage for RyR2-GFP was recorded 
over 5 minutes but failed to reach a complete plateau. However, general bleaching caused by 
image acquisition precluded recording longer than this time. Both CEPIA and soluble GFP 
fluorescence recovery was recorded for a total of 3 minutes, where a plateau was reached 





Figure 7: (A) Mean FRAP % data for CEPIA, soluble GFP and RyR2-GFP. n = 6, 8, 10 cells respectively. Results are 
expressed as means ± SEM. (B) Non-linear regression curves for the mean FRAP %for CEPIA, soluble GFP and RyR2-GFP.  
3.1.1 Mobile and immobile fraction 
The incomplete recovery seen for both soluble GFP (77.36 ± 1 %) and RyR2-GFP (76.2 ± 1.4 
%) in Figure 7 can be attributed to the immobile fraction. The immobile fraction refers to the 
particles within the bleached region that remain stationary or immobilized throughout the 
recovery process. In contrast, the fraction of particles contributing to the fluorescence recovery 





vs 21.4 ± 12.93 %, respectively. p > 0.05) showed no significant difference with a Kruskal-
Wallis test. It is unclear why CEPIA recovered to a mean FRAP % of 111.25 ± 0.74 % but as 
it is > 100 % it contained no immobile fraction.  
 
3.1.2 K Value 
The rate constant (K value) is a measure of how quickly the non-linear regression curve reaches 
its plateau and is measured in inverse seconds (Figure 8). Comparing the K values with a 
Kruskal-Wallis statistical test shows a significantly lower (~9-fold) rate constant of RyR2-GFP 
compared with CEPIA (0.008 ± 0.0007 vs 0.07 ± 0.009 s-1, respectively. p < 0.05). Similarly, 
comparing RyR2-GFP with soluble GFP also showed a significantly lower (38-fold) between 
rate constant means (0.008 ± 0.0007 vs 0.3 ± 0.1 s-1, respectively. p < 0.001). No significant 






Figure 8: K values for CEPIA, soluble GFP and RyR2-GFP measured in inverse seconds. n = 6, 8, 10 cells respectively.  
Kruskal-Wallis non-parametric test was used to test for significance. * p < 0.05 *** p < 0.001. Values are shown as a mean ± 
SEM. 
3.1.3 Half-life 
Half-life corresponds to the time it takes for the FRAP % to reach half of the plateau value 
(Figure 9). A Kruskal-Wallis comparison between the half-life of each protein shows an 11-
fold increase in time taken to reach plateau of RyR2-GFP compared to the ER entrapped 
CEPIA protein (87.63 ± 8.8 vs 7.99 ± 3.8 s, respectively. p < 0.05). Similarly, we see a 9-fold 
difference in the half-life of RyR2-GFP compared to a soluble GFP protein (87.63 ± 8.8 vs 9.6 
± 1.1 s, respectively. p < 0.001). No significant difference exists between CEPIA and soluble 





Figure 9: Half-life for CEPIA, soluble GFP and RyR2-GFP measured in seconds. n = 6, 8, 10 cells respectively. Results 
are expressed as means ± SEM. Kruskal-Wallis non-parametric test was used to test for significance. * p < 0.05, ***p < 0.001. 
3.1.4 Diffusion Coefficient 
The diffusion coefficient is calculated using the half- life obtained from the non-linear 
regression curve and is directly related to the mobility of the particles (Figure 10). As expected, 
RyR2-GFP diffusion coefficient follows a similar trend to both the K values and half-life and 
is significantly reduced by ~9-fold compared to CEPIA (0.017 ± 0.001 vs 0.15 ± 0.01µm2s-1, 
respectively. p < 0.05) and ~35-fold compared to soluble GFP (0.017 ± 0.001 vs 0.6 ± 0.2 
µm2s-1, respectively. p < 0.001). No significant difference was seen between CEPIA and 





Figure 10: Diffusion Coefficient for CEPIA, soluble GFP and RyR2-GFP measured in µm2 per second. n = 6, 8, 10 cells 
respectively. Results are expressed as means ± SEM. Kruskal-Wallis non-parametric test was used to test for significance. * p 
< 0.05 *** p < 0.001. 
3.2 Single protein (RyR2 cluster) movement  
After determining the characteristics of bulk RyR2 movement compared to CEPIA and GFP 
the movement of individual RyR2 clusters was explored. TIRF analysis of HEK293 cells 
containing both RyR2-GFP and CEPIA was used to analyse and further discriminate single 
RyR2 clusters by tracking their motion in a two-dimensional xy plane. TIRF analysis allows 
isolation of a cross-sectional image through our cells and can image an optical section within 
200 nm from the boundary of the coverslip. It also allows comparison of the approximate speed 
of singular RyR2-GFP particles across multiple independent cells. Figure 11 shows a wide 
field view of our labelled cells indicating the resolution gained from the CFI Apo TIRF 60x oil 
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objective. A clear reticular pattern (webbing) can be resolved, indicative of the ER of the cell. 
Comparison between Figure 5 and Figure 11 demonstrates the resolution difference in bulk 
motion FRAP analysis and single protein TIRF analysis. 
 
Figure 11: Wide field laser scanning confocal image of RyR2-GFP fluorescently labelled HEK293 cells. Image taken on 
an inverted Nikon Eclipse Ti-E2 with a CFI Apo TIRF 60x NA 1.49 oil objective.  
Due to covid related delays, only three RyR2-GFP clusters were able to be fully monitored 
over time (Figure 12, 13, and 14) and their motion was tracked, allowing an estimation of their 
diffusion speed and movement patterns. Although very difficult to resolve in static images, 
Figure 12 illustrates a single RyR2 cluster moving 3.44 microns over 1 minute and 43 seconds 
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at a speed of ~0.033 µm. s-1 (33.36 nm.s-1). This particle follows an irregular pattern and show 
a change in direction in the “83.4 Sec” panel. 
 
Figure 12: TIRF image of labelled RyR2 following a non-linear path in HEK293 cells. Areas of interest have been circled 
in red and the start and end of a single RyR2-GFP particle have been indicated. Total distance travelled = 3.44 µm and images 
are 20.6 sec. apart. 
Surprisingly, Figure 13shows a single RyR2 cluster that follows a more linear path of 4.35 µm 
in 21.9 seconds at an approximate speed of ~0.198 µm.s-1 (198 nm. s-1). Comparing the speed 
of the particles in both Figure 12 and 13, particles traveling in a linear fashion appear to travel 
faster (6-fold increase in speed) than those with a less direct path (0.033 vs 0.198 µm. s-1). 
However, as these are only two observations it is impossible to know whether this is a real 





Figure 13: TIRF image of labelled RyR2 particles following a linear path in HEK293 cells. Areas of interest have been 
circle in red. Estimation of the particles start and end point have been indicated in last recording frame. Total distance travelled 
was 4.35 µm. Images were taken 3.4 seconds apart. 
Interestingly, larger RyR2 particles (Figure 14) appear not to move over micro-meter distances 
but almost remain stationary over a 1 minute and 15 second time period. Frame “0 Sec” shows 
a large RyR2 cluster circled in red. We see no movement of this particle over 75 seconds 
showing it remains stationary throughout our recording. Again, whilst tempting to do so, it is 
not possible to determine whether this is a real difference in movement, due to cluster size, 
from the purely observational data collected so far. But this could account for the immobile 





Figure 14: TIRF image of labelled RyR2 particles remaining stationary in HEK293 cells. Areas of interest are circled in 
red. Stationary RyR2 particle is labelled with a white arrow. Images were taken 37.5 sec. apart. 
After confirming the ability to resolve and follow single RyR2-GFP clusters next, RyR2-GFP 
(488 nm excitation laser) and CEPIA (561 nm excitation laser) movement were recorded 
simultaneously. CEPIA is freely soluble within the ER compartment and thus allows a 
visualization of the complete ER network. In Figure 15 ER tubules have been estimated with a 
white line. As can be expected within a fluid, living cell the ER network can be seen moving 
over time (line shape changes). Between the “0 Sec” and “7.5 Sec” frames of we see an increase 
in the fluorescence intensity of the labeled RyR2 particle as it moves into the imaging plane. 
Excitingly, although difficult to appreciate in a static image series, the merged channel suggests 
that the lateral movement of an RyR2 particles follows the ER tubule structures shown in white. 
Overall, the RyR2 particle seen in Figure 15 moves a total of 1.26 µm over 30 seconds at an 
approximate speed of 0.042 µm.s-1. This is a similar speed to the particle seen Figure 12 (0.033 





Figure 15: Simultaneous dual-channel recording of both RyR2-GFP and CEPIA. A singular RyR2 cluster is shown 





The most common hypothesis held for the primary pathophysiological events occurring in AD 
is the amyloid beta cascade hypothesis, which states the overaccumulation of Aβ peptide is 
essential for the development of the disease (Hardy & Higgins, 1992; McGeer & McGeer, 
2013). Despite the intense research efforts focusing on this hypothesis, treatment options 
remain slim. It is well established that Aβ does indeed accumulate in AD to neurotoxic levels 
(George-Hyslop et al., 1989; Tanzi & Bertram, 2005), however recent evidence begins to 
implicate the breakdown of synaptic communication as a potential causative agent in the 
cognitive deficits seen in AD rather than Aβ directly (Lipton et al., 2001; Citri & Malenka, 
2008; Südhof et al., 2009; Adasme et al., 2011). New hypotheses indicate the dysregulation of 
Ca2+ signaling via RyR2 in synaptic transmission could directly result in an AD phenotype 
(Jorge et al., 2003; Giacomello et al., 2005; Chakroborty & Stutzmann, 2011). Why this occurs 
however, remains unknown. In other tissues, the function of RyR2 is highly dependent on its 
precise localization and organization within the cell. In the heart for example, the trafficking 
of RyR2 to the cardiac dyad has been shown as essential for a lower propensity of Ca2+ leak 
(Kolstad et al., 2018). Whether this also underlies the dysregulation of Ca2+ signaling at the 
synapse has yet to be explored.  
 
RyR2 is present in both the soma and at the synapse where it is an important driver of 
neurotransmitter release (Sharp et al., 1993). Whether RyR2 is directly trafficked from the 
soma to the synapse or relies on basic diffusion parameters is unknown. Liu et al. have depicted 
that RyR2 can form a complex with KIF3A, a member of the kinesin-2 motor protein family 
(Liu et al., 2014b). This is the first quantifiable evidence to suggest that RyR2 may be trafficked 
to the synapse. However, both somatic and synaptic RyR2 motion is also likely to be governed 
by random thermal motion, as is seen for similar ER membrane proteins (Ramadurai et al., 
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2009). As a first step toward defining RyR2 movement in neurons, this thesis studied the 
Brownian (random thermal) motion of RyR2-GFP in a HEK293 cell model using FRAP. 
HEK293 cells demonstrate a less organized cellular structure compared to hippocampal 
neurons, and do not endogenously express RyR2, so are unlikely to have specific trafficking 
mechanisms for it. Hence these cells are a model of Brownian movement of RyR2 rather than 
targeted localization. This work creates a robust FRAP and TIRF methodology for future work 
in hippocampal neurons. It was hypothesized that RyR2-GFP will move slower than other 
protein markers of diffusion within the ER and the cytosol and would travel along isolated ER 
tubules, restricting its movement within the cell. Elucidating the basic characteristics of RyR2 
movement in the ER of an unordered cell will develop a much-needed baseline for local 
somatic and synaptic RyR2 movement, before exploring RyR2’s trafficking properties. 
 
4.1 Bulk movement  
In cells, the various cell membranes host numerous integral proteins. Along with membrane 
lipids and other macromolecules these proteins are thermally driven to diffuse laterally, 
forming protein oligomers and lipid-protein complexes (Javanainen et al., 2017). Membranes 
within most cells are highly heterogeneous, partitioned, and rich in proteins with the average 
in plane distance between proteins averaging just a few nanometers (Kusumi et al., 2005; Zhou 
et al., 2008). Fick’s law of diffusion states that the thermal movement of a particle is dependent 
on the viscosity of the medium in which it is located. This suggests that particle dynamics differ 
between membrane bound proteins and soluble proteins as a lipid bilayer is much more viscous 
than the aqueous intracellular fluid. This highlights, proteins containing transmembrane 
domains face challenges that soluble proteins do not. The densely packed ER is an example of 
a viscous intracellular membrane rich with proteins, however characterization of diffusion in 
the nanoscale environment have been continuously difficult. 
 
 38 
4.1.1 RyR2 FRAP analysis 
The first aim was to analyse the diffusion parameters extracted from individual FRAP recovery 
curves to understand the basic Brownian motion of RyR2 in the ER membrane. In this instance, 
fluorescence recovery refers to the movement of non-bleached molecules moving into the 
region of interest and bleached molecules moving out rather than the fluorescent protein’s 
ability to regain its fluorescence. Soluble GFP was used for comparison with RyR2-GFP as it 
represents a small soluble protein, whereas CEPIA was used as it represents a soluble but ER 
entrapped protein.  
 
The rate constant (K value) is a measure of how quickly a non-linear regression curve reaches 
its plateau and is measured in inverse time. Figure 8 shows the rate constant (K value) for RyR2 
is significantly decreased compared to both CEPIA (0.008 ± 0.0007 vs 0.07 ± 0.009 s-1) and 
soluble GFP (0.008 ± 0.0007 vs 0.3 ± 0.1 s-1). Indicating RyR2 takes much longer (10-30 times) 
for fluorescence to recover than both CEPIA and GFP. Figure 9 shows the half-life which is a 
calculated measure of the time in seconds (x axis) for the FRAP % (y axis) to reach half of its 
plateau. This value is directly proportional to the speed of the particle and unsurprisingly, 
RyR2-GFP had a significantly longer half-life than both CEPIA (87.63 ± 8.8 vs 7.99 ± 3.8 s) 
and soluble GFP (87.63 ± 8.8 vs 9.6 ± 1.1 s). This also shows that RyR2-GFP takes a longer 
time to recover, hence its movement must be slower. Surprisingly, comparison of both the rate 
constant and half-life between CEPIA and GFP showed no significant difference, suggesting 
these two proteins recover at similar speeds. This is unusual as CEPIA is both organelle 
entrapped and almost 4 times the size of soluble GFP (101.3 vs 28 kDa, respectively) (Hink et 
al., 2000; Akerboom et al., 2009). It would be easy to assume that because CEPIA is larger, 
and its movement is restricted to the ER its motion would be slower and hence take a longer 
time to recover. It remains unclear why we see no significant difference in diffusion parameters 
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between these two proteins. However, it could be attributed to the fairly large variation in 
values within both groups. Increasing the sample size may overcome this shortcoming allowing 
a difference to be observed.  
 
4.1.1.1 Diffusion coefficient 
The diffusion coefficient is a proportionality constant between the flux caused by diffusion and 
the concentration gradient existing between two terms. The higher the diffusion coefficient, or 
diffusivity, the quicker these two terms become analogous. It has been described in Fick’s law 
of diffusion and can be obtained from FRAP experiments using half-life of recovery (Fick, 
1855; Axelrod et al., 1976). Diffusion coefficient equations used for FRAP differ based on the 
laser used for photobleaching (Lorén et al., 2015) and were estimated following the equation 
for a Gaussian laser set out by Axelrod et al., in 1976 (Axelrod et al., 1976). The diffusion 
coefficient for RyR2-GFP is significantly (~9-fold) lower than that of CEPIA (0.017 ± 0.001 
vs 0.15 ± 0.01µm2s-1, respectively. p < 0.05). Similarly, we see the diffusion coefficient 
between RyR2-GFP is significantly (~35-fold) lower than soluble GFP (0.017 ± 0.001 vs 0.6 
± 0.2 µm2s-1, respectfully. p < 0.05). The diffusion coefficient is a value that is comparable 
across both different substrates and different experiments. Future comparison of the diffusion 
coefficient of RyR2 between normal hippocampal neurons and AD hippocampal neurons has 
the potential to determine if the movement of RyR2 is impaired in AD. This is not only valuable 
for cell versus cell comparison but also soma versus synapse (see below). For example, if we 
were to see a lower diffusion coefficient in AD neurons compared to normal hippocampal 




4.1.1.2 Immobile fraction and AD 
In a perfect system and over a long enough recording, it would be expected that all particles 
are able to move freely hence, fluorescence intensity recovers to the same value as before the 
bleach (i.e., FRAP % = 100%). However, a more realistic biological context introduces the 
complexity of stationary molecules. The fraction of immobilized or stationary molecules is 
referred to as the immobile fraction and is measured as the difference between 100% recovery 
and the recovery curve plateau. A Kruskal-Wallis test revealed there was no significant 
difference between the immobile fraction of RyR2-GFP and soluble GFP (14.29 ± 7.6 vs 21.4 
± 12.93 %, respectively. p > 0.05). Unexpectantly, CEPIA recovers above 100% (111.25 ± 
0.74 %) suggesting no immobile fraction exists and CEPIA has more than a complete recovery. 
However, because the resulting FRAP percentage exceeds 100% recovery, which is 
theoretically impossible, this result is highly unlikely and could be a result of systematic error. 
CEPIA excites optimally at a wavelength of 561 nm, however a 488 nm excitation laser was 
used across all proteins for photobleaching. FRAP relies on the irreversible photobleaching of 
an area of interest, however an inefficient bleach may have resulted in an incomplete photo 
bleach, hence overestimating the fluorescence recovery.  
 
GFP showed an immobile fraction of 21.4 ± 12.93 % showing that approximately 21 % of GFP 
molecules within the bleached area remain stationary resulting in a plateau below 100%, 
whereas RyR2-GFP exhibits an immobile fraction of 14.29 ± 7.6 %. Immobile fractions are a 
quantifiable measure that can be compared across multiple experiments and has the potential 
to be translated to future work in hippocampal neurons. The distribution of RyR2 throughout 
a neuron suggests that different areas of the cell may have different immobile fractions. For 
example, in neurons, RyR2 is highly concentrated both pre- and post-synaptically rather than 
showing an even distribution throughout the cell (Sharp et al., 1993). For proper synaptic 
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transmission RyR2 must remain localized to the axon terminal suggesting more immobile 
particles and hence a higher immobile fraction. In contrast, there is limited function of RyR2 
along the length of an axon suggesting more RyR2 particles will be mobile, hence a lower 
immobile fraction. Axonal transport is highly reliant on microtubule tracks regulated by a MAP 
known as tau. It has been shown that this protein can become hyperphosphorylated in AD 
forming neurofibrillary tangles and inhibiting axonal trafficking. This suggests a potential 
decrease in the number of mobile molecules travelling along the axon, hence increasing the 
immobile fraction seen in a FRAP experiment on AD neurons. 
 
4.1.1.3 FRAP limitations 
Visual analysis of the mean recovery curves alone (Figure 7) gives an immediate indication 
that RyR2 moves substantially slower than CEPIA and GFP. Both CEPIA and GFP were 
imaged for ~3 minutes as a complete plateau was reached within this time, whereas RyR2-GFP 
had yet to reach plateau and required at least a further 2 minutes. Even after a total of 5 minutes, 
RyR2-GFP did not reach a plateau. Unfortunately, as shown in Figure 16 it was not possible to 
record reliably for longer than 5 minutes due to excess bleaching of the cell by the acquisition 
laser. As can be seen in the final frames of Figure 16 the constant laser scanning of the cell 
used to capture the images, resulted in a significant loss of signal, magnifying the signal-to-
noise ratio restricting imaging for longer. Further optimization of the imaging technique, such 
as lowering the acquisition laser power, reducing the pinhole size, and using a shorter pixel 





Figure 16: Fluorescence recovery over 158 seconds for RyR2-GFP. Images are 7.5 seconds apart. Bleached area of 19.6 
µm2 is indicated by the white circle. Overall cell bleaching can be seen between the first image and the last. 
 
4.2 Single protein (RyR2 cluster) movement  
After determining the characteristics of bulk RyR2 movement, the movement of individual 
RyR2 clusters was explored. TIRF microscopy aimed to combat limitations intrinsic to FRAP 
experiments by isolating a thin optical slice hence, increasing resolution, and optimizing the 
signal-to-noise ratio. HEK293 cells overexpressing both RyR2-GFP and CEPIA were used to 
analyse and further discriminate single RyR2 clusters by tracking their motion in a two-
dimensional xy plane (lateral diffusion). TIRF microscopy can generate an optical section 
within 200 nm from the boundary of the coverslip. The small optical slice obtained by TIRF 
imaging may be seen as a weakness of this study, however isolation of a singular plane 
facilitates the high signal to noise ratio as well as creating low photobleaching and a high 
sensitivity (Grigoriev & Akhmanova, 2010). While tempting to assume we are imaging single 
RyR2-GFP clusters, with our current images it is impossible to determine if we are visualizing 
independently moving RyR2 clusters or multiple clusters moving in unison. Therefore, 




4.2.1 RyR2 movement speed 
The three images collected so far varied in estimated RyR2-GFP movement speeds with speeds 
ranging from 198 nm.s-1 to 33 nm.s-1. Figure 13 shows a single fluorescent punctum moving 
laterally in a linear path of 4.35 µm whereas, Figure 12 shows an RyR2 cluster following a 
more irregular pattern along 3.44 µm. At first glance when comparing the approximate speed 
of these two particles (0.033 vs 0.198 µm. s-1) it appears that particles travelling in a more 
linear fashion appear to travel faster (~6-fold increase in speed) than those with a less direct 
path. However, the low sample size (n number) makes it impossible to declare if this is a real 
phenomenon or pure coincidence. RyR2-GFP “clusters” with a larger lateral radius (Figure 14) 
showed no movement within the lateral plane over a total of 75 seconds indicating this particle 
remained stationary throughout the imaging process. Again, whilst easy to do so, it is not 
possible to determine whether this is a real correlation between “cluster” size and motility 
based on the purely observational data collected so far.  
 
The large range of estimated RyR2 movement speed is contradictory to previous research by 
Hiess et al., who described RyR2 movement speed in cardiomyocytes and showed a diffusion 
velocity of ~1 µm in 10 minutes or 1.5 nm.s-1(Hiess et al., 2018). Both studies use TIRF 
imaging, however we show an almost 22-fold increase in the movement velocity outlined in 
cardiomyocytes (33 vs 1.5 nm.s-1). A reason for this extreme difference could be a function of 
the cell type used. Hiess et al., completed their study using single ventricular myocytes from a 
GFP-RyR2 knock-in mouse whereas, human embryonic kidney cells (HEK293 cells) were 
used in this study. HEK293 cells are less organized than a cardiomyocyte and do not 
endogenously express RyR2, suggesting they do not contain the necessary cellular machinery 
needed for the directed movement or anchoring of RyR2 to local microdomains. Maintenance 
of a high concentration of RyR2 at the junctional SR in the cardiac dyad is essential for proper 
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contraction of a cardiomyocyte (Kolstad et al., 2018). Therefore, it is expected that RyR2 
movement away from the cardiac dyad is limited (larger immobile fraction). In contrast, the 
localization of RyR2 into distinct microdomains has no benefits for the survival of HEK293 
cells and hence we see diffused RyR2 throughout the entire cell (Figure 17). To the best of our 
knowledge, these images are the first to look at the distribution pattern of RyR2 in HEK293 
cells. As HEK293 cells do not possess the needed machinery to traffic RyR2 to localized areas 
within the cell, its motion is likely entirely driven by Brownian motion. 
 
Figure 17: Distribution of RyR2 in cardiomyocytes (A and B) and HEK293 cells (C). (A) and (B) T-tubules are shown in 
blue and single RyR2 clusters can be seen in pink. RyR2 cluster formation is localised to the terminal SR within the cardiac 
dyad. (C) Distribution of RyR2 in HEK293 cells is even throughout the entire cell except for the nucleus. Image adapted 
from (Shen et al., 2019). 
If RyR2 molecules remain localized to the cardiac dyad, the resultant diffusion velocity would 
be low, similar to the intra-cluster rearrangement speed seen by Hiess et al. (Hiess et al., 2018). 
In contrast, RyR2 expressed in HEK293 cells do not need to remain localized hence increasing 
the diffusion velocity observed.  
 
4.2.2 RyR2 moves parallel with ER tubules 
Figure 15 illustrates a simultaneous multiple channel recording using two sperate excitation 
lasers (488 nm for GFP and 561 nm for CEPIA). We can see in the “0 Sec” frame a distinct 
punctum moves into the imaging plane and begins to divert laterally in sequential frames. It 
can often be hard to discriminate the dynamic movement of the ER with a static image series, 
however, the ER has been shown as a highly dynamic structure (Espadas et al., 2019). This 
makes it difficult to determine whether RyR2-GFP is moving independently of the ER or 
A B C 
 
 45 
whether the dynamic movement of the ER is causing the movement seen in these images or a 
combination of both. The 561 nm laser is used to excite CEPIA which acts as an indicator of 
the ER allowing us to estimate the size and location of ER tubules (Figure 15 highlighted in 
white). Merging both the 488 nm and 561 nm channels we can see labelled RyR2 clusters 
appear to follow the tubular pattern outlined by CEPIA. Although it appears that RyR2-GFP 
travels along these ER tracks, we must consider that this is an isolated image sequence and 
only estimates can be drawn from these results. However further optimization of this 
methodology could elucidate movement patterns for not only RyR2-GFP but other 
fluorescently tagged proteins as well. Further research is needed to conclusively state that 
RyR2-GFP moves throughout the cell along ER tubules. As RyR2 movement appears not to 
be isolated to the dynamics of the ER, this suggests a multifactorial component to the overall 
diffusion of RyR2. For example, half of the movement velocity of RyR2 could be attributed to 
the movement of the ER, while the other half is a result of the lateral membrane diffusion of 
RyR2.  
 
4.2.3 TIRF limitations 
Covid related delays significantly reduced the number of cells that were imaged using TIRF 
microscopy, hence reducing these results to purely qualitative. A higher sample number (n) 
may have resulted in an RyR2 diffusion speed more comparable to the one outline by Hiess et 
al. in cardiomyocytes. The thin optical slice obtained in TIRF limits recording molecule 
movement to the lateral plane. Diffusion is a process that occurs in three dimensions, thus 
recording only the lateral movement may be eliminating a large portion of a single RyR2 
clusters movement. For example, recording of a fluorescent punctum beginning in the lateral 
plane may only encapsulate a small portion of the entire RyR2s movement. Therefore, if RyR2 
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was moving at different speeds at different times we are only capturing a low portion of the 
average diffusion velocity.  
 
4.3 Future directions 
Both FRAP and TIRF microscopy have been shown as invaluable for understanding the normal 
movement of RyR2 in a HEK293 cell model. These methods have great potential for further 
optimization and use in hippocampal neurons to reveal somatic versus synaptic diffusion 
characteristics. Whether these results differ in normal hippocampal neurons and AD 
hippocampal neurons may elucidate if altered RyR2 movement may be resulting in the 
increased Ca2+ leak seen in AD.  
 
4.4 Conclusion 
To conclude, RyR2-GFP has slower movement dynamics compared to CEPIA and GFP and 
appears to travel within ER tubules. Although the ultrastructural organization and movement 
of RyR2 is essential in several tissues, research remains limited about its movement 
characteristics in neurons. This research aimed to take the first steps by prioritizing quantifiable 
movement characteristics of RyR2 in a HEK293 cell model. Elucidating the basic 
characteristics of RyR2 movement in the ER of an unordered cell develops a much-needed 
baseline for local somatic and synaptic RyR2 movement, before exploring RyR2’s trafficking 
properties in neurons. Axonal transport is highly reliant on tau, which is characteristically 
hyperphosphorylated in AD creating neurofibrillary tangles and inhibiting axonal trafficking. 
This suggests a potential decrease in the number of mobile molecules travelling along the axon, 
hence increasing the immobile fraction seen in a FRAP experiment on AD neurons. To the best 
of our knowledge RyR2 cluster size is increased at the synapse in an APP/PS1 (delExon9) 
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model of AD (Vergara, 2020). However, it is yet to be examined if this is caused by alterations 
in the balance between retrograde and anterograde trafficking, an alteration in the normal 
diffusion characteristics of RyR2 or an entirely different mechanism. An increase in the 
immobile fraction of RyR2 in the synapse could result in the increased expression and cluster 
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